www.marcusevans.com
Open in
urlscan Pro
2620:1ec:bdf::45
Public Scan
Submitted URL: https://email.me-conferences.co.uk/c/14sffUWXoodfcg3hz9h8vc7nVihao
Effective URL: https://www.marcusevans.com/conferences/ppmpharma/delegate/programme
Submission: On April 26 via manual from HK — Scanned from DE
Effective URL: https://www.marcusevans.com/conferences/ppmpharma/delegate/programme
Submission: On April 26 via manual from HK — Scanned from DE
Form analysis 1 forms found in the DOM
<form class="mt-3 form-inline ng-pristine ng-invalid ng-invalid-required">
<div class="form-group">
<input type="email" ng-model="model.newsLetterEmailAddress" class="form-control ng-pristine ng-valid-email ng-invalid ng-invalid-required" required="" id="Email" aria-describedby="EmailHelp" placeholder="Enter email address to signup">
<!-- ngIf: isSendingNewsletter === false --><button ng-if="isSendingNewsletter === false" type="submit" class="btn ng-binding ng-scope" ng-click="doNewsLetterSubscribe()">Subscribe</button><!-- end ngIf: isSendingNewsletter === false -->
<!-- ngIf: isSendingNewsletter === true -->
<p class="mt-2 small-body form-help-text ng-binding">We'll never share your email with anyone else.</p>
</div>
</form>Text Content
marcusevans A global, multifaceted media, corporate marketing and information
company.
marcusevans 40th Year Celebration
Enquire Now
1. Home
2. Programme
25th edition
STRATEGIC PROJECT & PORTFOLIO MANAGEMENT FOR PHARMA
Optimising tools and processes to drive PPM efficiency and steer high efficiency
projects
2024, 06, 3
Event starts in: days
* 3 June - 5 June 2024
* Renaissance Hotel
* Barcelona‚ Spain
SPEAKERS INCLUDE
PAST SPEAKERS INCLUDE
Giuseppe Ciavarro
Head Portfolio Effectiveness
Novartis, USA
Vatsala Sadasivan
Global Operational Excellence Lead, R&D
Sanofi, USA
Alaina Kupec
Executive Director, Portfolio Strategy & Analytics
Gilead Sciences, USA
Alpesh Mistry
Director R&D Portfolio Management
Novo Nordisk, Denmark
Magali Musarella
Strategy and Portfolio Manager at Roche pRED
Roche, Switzerland
Amit Arkad
Director R&D Project Management - mRNA Vaccines
GSK, Belgium
Virginie Turc
Head of PM Office and Governance
UCB, Belgium
Marc Soriano
R&D Project Portfolio and Partnership Excellence, Senior Director
Almirall, Spain
Frank Berger
Head of Analytics, Global Clinical Operations
Boehringer Ingelheim, Germany
Emma Barton
Director, Alliance and Integration Management
AstraZeneca, UK
Anne-Cécile Rimaniol
Programs & Portfolio Excellence Director
Servier, France
Irina Chublukova
Head of Product Portfolio
Polpharma Group B.V., The Netherlands
Maria Åkerman
Global Programs Director
Affibody AB, Sweden
Harm Jan Hemsing
Co-founder of NíoSync - Former Head of business planning at Alkermes
Ivan Kugener*
Vice President, Head of Global Portfolio Management & Decision Science
Merck, USA
Marianna Esposito, Ph.D.
Director of Business Development, Europe
Intelligencia AI, UK
Deepak Veeraraghavan
Partner & Practice Lead Global Life Science
Strategic Decisions Group
Matthew Kokkonen
Director, Client Strategy Management
Captario
Maciej Szymaszek
Senior Director, Strategy Implementation & Business Transformation at Global
Portfolio & Project Management
AstraZeneca, USA
Paul Shaw
Vice President, EPMO
Sosei Heptares, UK
Gilles Brackman
Vice President R&D
Flen Health, Belgium
Gitana Vaičiulytė
PMO, Transformation Program Manager
Terumo Europe, Belgium
Kamil Mroz
Director, Gene Therapy Program Management Lead (EPVM)
UCB, Belgium
Andreas Janzer
Global Program Manager Oncology Development
Bayer, Germany
AGENDA
Day 1
3.6.2024
6.3.2024
* 08:30 8:30 AM
Registration and Coffee
* 09:00 9:00 AM
Opening Address from the Chair
* STRATEGIC FRAMEWORK TO SUPPORT DECISION MAKING
* 09:10 9:10 AM
Case Study
Achieving alignment and impact: Creating fit-for-purpose architecture for
strategic success
* Align Strategy, Stakeholders and Projects
* Design and empower self-managed teams with laser-focus purpose
* Discover how strategy, portfolio and project management play a pivotal
role in identifying and catalyzing opportunities within a R&D organization
Magali Musarella
Strategy and Portfolio Manager at Roche pRED
Roche, Switzerland
For
Magali Musarella
Strategy and Portfolio Manager at Roche pRED
Roche, Switzerland
Panel Moderated By
Magali Musarella
Strategy and Portfolio Manager at Roche pRED
Roche, Switzerland
* 09:50 9:50 AM
Case Study
Best Practices for Engaging with Senior Management
* Understand the mandate of Project and Portfolio Managers
* Create strong lines of communication that are simple, yet effective
* Ensure continuous development towards key priorities
Amit Arkad
Director R&D Project Management - mRNA Vaccines
GSK, Belgium
For
Amit Arkad
Director R&D Project Management - mRNA Vaccines
GSK, Belgium
Panel Moderated By
Amit Arkad
Director R&D Project Management - mRNA Vaccines
GSK, Belgium
* 10:30 10:30 AM
Refresh Me
* EARLY STAGE PORTFOLIO STRATEGIES
* 11:00 11:00 AM
Case Study
Simplifying Complexity for Quality Decision-Making: A Quantitative Approach
to Early Asset- and Portfolio Decision-Making
The complexity of developing assets, considering commercial potential,
development costs, development risks, timelines, and other factors, can be
daunting. Alaina Kupec (Gilead) and Deepak Veeraraghavan (Strategic Decisions
Group) will introduce a quantitative approach to decision-making amidst the
uncertainties of early-stage asset and portfolio management. This session
will provide insights into integrating decision quality into portfolio and
asset-level strategies, addressing these complexities. SDG and Gilead will
present a general overview and a compelling case study showing the practical
application of the methodology to refine an early-stage development asset
strategy.
Alaina Kupec
Executive Director, Portfolio Strategy & Analytics
Gilead Sciences, USA
Deepak Veeraraghavan
Partner & Practice Lead Global Life Science
Strategic Decisions Group
For
Alaina Kupec
Executive Director, Portfolio Strategy & Analytics
Gilead Sciences, USA
Deepak Veeraraghavan
Partner & Practice Lead Global Life Science
Strategic Decisions Group
Panel Moderated By
Alaina Kupec
Executive Director, Portfolio Strategy & Analytics
Gilead Sciences, USA
Deepak Veeraraghavan
Partner & Practice Lead Global Life Science
Strategic Decisions Group
* 11:40 11:40 AM
Case Study
Methodologies in The Management of Early Drug Pipeline Portfolios
Alpesh Mistry
Director R&D Portfolio Management
Novo Nordisk, Denmark
For
Alpesh Mistry
Director R&D Portfolio Management
Novo Nordisk, Denmark
Panel Moderated By
Alpesh Mistry
Director R&D Portfolio Management
Novo Nordisk, Denmark
* 12:20 12:20 PM
Case Study
Level Up Your Strategic Portfolio Decision-Making With AI
AI is here to stay. Will you embrace it to bring your portfolio and asset
strategy to the next level? Join us for an interactive session
on why AI should be part of your toolkit, how it fits into
your organization’s workflows, and where it can increase decision-making
confidence.
Marianna Esposito, Ph.D.
Director of Business Development, Europe
Intelligencia AI, UK
For
Marianna Esposito, Ph.D.
Director of Business Development, Europe
Intelligencia AI, UK
Panel Moderated By
Marianna Esposito, Ph.D.
Director of Business Development, Europe
Intelligencia AI, UK
* 13:00 1:00 PM
Lunch
* OPTIMIZING PORTFOLIO MANAGEMENT
* 14:00 2:00 PM
Case Study
Create a Strong R&D Pipeline through portfolio effectiveness
* Anticipate the long-term value creation potential of projects.
* Look at individual project characteristics as well as it’s fit within the
entire portfolio.
* Ensure a consistent stream of new ideas to feed the pipeline
Irina Chublukova
Head of Product Portfolio
Polpharma Group B.V., The Netherlands
For
Irina Chublukova
Head of Product Portfolio
Polpharma Group B.V., The Netherlands
Panel Moderated By
Irina Chublukova
Head of Product Portfolio
Polpharma Group B.V., The Netherlands
* 14:40 2:40 PM
Panel Discussion
Explore the impact of data analytics, AI and machine learning applied to R&D
portfolio management
* Understanding the growing hype in AI/ML and its application in portfolio
* Case study on how AI/ML can support organisation in predicating project
progress
* 15:20 3:20 PM
Refresh Me
* 15:50 3:50 PM
Case Study
Balancing Short-Term and Long-Term Goals in Portfolio Planning
Giuseppe Ciavarro
Head Portfolio Effectiveness
Novartis, USA
For
Giuseppe Ciavarro
Head Portfolio Effectiveness
Novartis, USA
Panel Moderated By
Giuseppe Ciavarro
Head Portfolio Effectiveness
Novartis, USA
* 16:30 4:30 PM
Case Study
Articulate your priorities better in an uncertain environment
* Balance financial and scientific value to ensure Project& portfolio
alignment with strategic goals
* Balance internal investments with external resources and partnships
* Diversify the portfolio within specific therapeutic are
Marc Soriano
R&D Project Portfolio and Partnership Excellence, Senior Director
Almirall, Spain
For
Marc Soriano
R&D Project Portfolio and Partnership Excellence, Senior Director
Almirall, Spain
Panel Moderated By
Marc Soriano
R&D Project Portfolio and Partnership Excellence, Senior Director
Almirall, Spain
* 17:15 5:15 PM
Closing Comments from Chair and End of Day One
Day 2
4.6.2024
6.4.2024
* 08:30 8:30 AM
Registration and Coffee
* 09:00 9:00 AM
Opening Address from the Chair
* BUILDING STRONG ORGANIZATIONAL STRUCTURES AND MAXIMIZING INTERNAL
CAPABILITIES TO DRIVE SUCCESS
* 09:10 9:10 AM
Case Study
Implementing a Governance Model aimed at simplifying decision making
* Developing a two steps process to validate project selection
* Involving various stakeholders and teams to confirm project is aligned
with overall company strategy
* Leveraging decision making to help project portfolio prioritisation
Virginie Turc
Head of PM Office and Governance
UCB, Belgium
For
Virginie Turc
Head of PM Office and Governance
UCB, Belgium
Panel Moderated By
Virginie Turc
Head of PM Office and Governance
UCB, Belgium
* 09:50 9:50 AM
Case Study
Deploying a large scale strategic portfolio management
Session to be updated
Anne-Cécile Rimaniol
Programs & Portfolio Excellence Director
Servier, France
For
Anne-Cécile Rimaniol
Programs & Portfolio Excellence Director
Servier, France
Panel Moderated By
Anne-Cécile Rimaniol
Programs & Portfolio Excellence Director
Servier, France
* 10:30 10:30 AM
Refresh Me
* 11:00 11:00 AM
Case Study
Partner session
BDO Consulting
* 11:40 11:40 AM
Case Study
Develop an Operational Excellence roadmap to drive the execution of the R&D
strategy
Vatsala Sadasivan
Global Operational Excellence Lead, R&D
Sanofi, USA
For
Vatsala Sadasivan
Global Operational Excellence Lead, R&D
Sanofi, USA
Panel Moderated By
Vatsala Sadasivan
Global Operational Excellence Lead, R&D
Sanofi, USA
* 12:20 12:20 PM
Case Study
Partner session
Captario
* 13:00 1:00 PM
Lunch
* INTEGRATION AND ALIGNEMENT IN THE PORTFOLIO
* 14:00 2:00 PM
Case Study
Clinical trials: success factors for your pharma portfolio
* Understand the unique challenges for project management of clinical
trials.
* Build on the tools, strategies and best practices developed in recent
years.
* Lessons learned that can be applied to broader PPM strategies
Session on final confirmation
Frank Berger
Head of Analytics, Global Clinical Operations
Boehringer Ingelheim, Germany
For
Frank Berger
Head of Analytics, Global Clinical Operations
Boehringer Ingelheim, Germany
Panel Moderated By
Frank Berger
Head of Analytics, Global Clinical Operations
Boehringer Ingelheim, Germany
* 14:40 2:40 PM
Case Study
Absorbing external assets into a portfolio pipeline
* How does it fit within the overall portfolio management
* Case study on in-licensing or M&A scenario
* How to ensure a smooth landing without dela
Emma Barton
Director, Alliance and Integration Management
AstraZeneca, UK
For
Emma Barton
Director, Alliance and Integration Management
AstraZeneca, UK
Panel Moderated By
Emma Barton
Director, Alliance and Integration Management
AstraZeneca, UK
* 15:20 3:20 PM
Refresh Me
* 15:50 3:50 PM
Case Study
Maintain a pipeline and portfolio as a small biotech company
Maria Åkerman
Global Programs Director
Affibody AB, Sweden
For
Maria Åkerman
Global Programs Director
Affibody AB, Sweden
Panel Moderated By
Maria Åkerman
Global Programs Director
Affibody AB, Sweden
* 16:20 4:20 PM
Case Study
MidCap Portfolio Management – A different discussion
* Competing for corporate capital – Portfolio management in small and midcap
companies goes beyond R&D investment decisions
* Numbers are only part of the story – A more strategic and less
mathematical approach to capital allocation
* Keeping it on track – Structuring analyses, debates and decision making
processes for success
Harm Jan Hemsing
Co-founder of NíoSync - Former Head of business planning at Alkermes
For
Harm Jan Hemsing
Co-founder of NíoSync - Former Head of business planning at Alkermes
Panel Moderated By
Harm Jan Hemsing
Co-founder of NíoSync - Former Head of business planning at Alkermes
* 17:00 5:00 PM
Closing Comments from Chair and End of Day Two
Post Conference Workshop
5.6.2024
6.5.2024
* 08:30 8:30 AM
Workshop
Developing Project & Portfolio Management Competencies to Support
Decision-Making
In this half-day workshop, participants will have the opportunity to learn
from the approaches, skills and tools their peers implement in order to solve
problems and navigate difficult situations. Ultimately, building-up their
capacity to turn challenges into opportunities and maximize their role as
project & portfolio managers. After an introductory presentation,
participants will explore few case studies, each posing a different problem.
Each table group will work autonomously on one case for about 30 minutes,
discussing different aspects and possible solutions. Then participants will
move on to the next table to dive into another topic. All the discussion
results will be written down. At the end of the session, results from each
table will be discussed.
08.30 Registration and Coffee
09.00 Introduction and Opening Remarks
09.15 Scenario One
10:30 Refresh Me
11.00 Scenario Two
12.30 Closing Remarks and End of Workshop
Frank Berger
Head of Analytics, Global Clinical Operations
Boehringer Ingelheim, Germany
For
Frank Berger
Head of Analytics, Global Clinical Operations
Boehringer Ingelheim, Germany
Panel Moderated By
Frank Berger
Head of Analytics, Global Clinical Operations
Boehringer Ingelheim, Germany
Ola Samuelsson
European Research & Marketing Director
0044 203 002 3276 OlaS@MarcusEvansUK.com
Keep up to date with all marcus evans Conference news via our social media
channels
Newsletter
Subscribe to the marcus evans Conference newsletter to keep up to date with all
our events
Subscribe
We'll never share your email with anyone else.
marcusevans 40th Year Celebration
A global, multifaceted media, corporate marketing and information company,
employing 3000 professionals in 59 worldwide locations. Our activities are wide
ranging, providing up-to-the-minute information for businesses and professionals
worldwide.
Copyright © 2024 marcusevans Group.
* Legal
* Terms & Conditions
* Privacy Policy
* Cookies Policy
* Modern Slavery
Close
TO VIEW THE FULL INFORMATION PLEASE SIGN UP
Email Address
Please enter a valid email address.
Please enter your work email address.
We'll never share your email with anyone else.
Send Close
THANK YOU
Thank you for providing your email address. You can now access all areas of the
site.
Close
THANK YOU
Thanks for your newsletter signup we will add you to the list.
Close